Creatine causes platelets to become overactive and promotes the spread of cancer. This effect requires a specific enzyme, creatine kinase B (CKB), in the cells that produce platelets. CKB activates a signaling molecule (STAT5B) that turns on genes responsible for platelet function.
See the scientific wording
Creatine-induced platelet hyperactivity and metastasis depend on megakaryocyte-specific creatine kinase B (CKB) expression because CKB upregulation is necessary for non-canonical STAT5B phosphorylation, which drives platelet functional gene expression.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyHuman2026
This study shows that taking creatine makes platelets more active and helps cancer spread in mice, and this only happens when a specific enzyme (CKB) and a protein (STAT5B) in platelet-producing cells are working.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When you take creatine, it enters cells that make platelets in your bone marrow. There, it turns on an enzyme called CKB. This enzyme modifies a protein called STAT5B by adding a phosphate group. The changed STAT5B then switches on genes that make platelets more active. These hyperactive platelets help cancer cells spread to new places in the body.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine causes platelets to become overactive and promotes the spread of cancer. This effect requires a specific enzyme, creatine kinase B (CKB), in the cells that produce platelets. CKB activates a signaling molecule (STAT5B) that turns on genes responsible for platelet function.
Mechanism
1 studyCreatine makes platelets hyperactive by turning on a specific enzyme and a signaling protein inside platelet-producing cells. This change makes platelets more sticky and helps cancer spread. Blocking any step in this process stops the effect.
When you take creatine, it enters cells that make platelets in your bone marrow. There, it turns on an enzyme called CKB. This enzyme modifies a protein called STAT5B by adding a phosphate group. The changed STAT5B then switches on genes that make platelets more active. These hyperactive platelets help cancer cells spread to new places in the body.
Exogenous creatine enters megakaryocytes, increasing intracellular creatine levels.
Elevated creatine upregulates creatine kinase B (CKB) expression in megakaryocytes.
CKB directly phosphorylates STAT5B at a non-canonical site, activating it.
Phosphorylated STAT5B drives transcription of platelet functional genes, increasing platelet reactivity.
Hyperactive platelets promote tumor cell dissemination and metastasis.
Evidence from Studies
Supporting (1)
Community contributions welcome
Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.
This study shows that taking creatine makes platelets more active and helps cancer spread in mice, and this only happens when a specific enzyme (CKB) and a protein (STAT5B) in platelet-producing cells are working.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Preclinical Studies on CKB-Dependent Creatine-Induced Platelet Hyperactivity and Metastasis
A systematic review and meta-analysis of all available in vitro and animal studies examining the effect of creatine on platelet function and metastasis in models with and without CKB expression. Studies should include measures of platelet hyperactivity (e.g., aggregation, adhesion) and metastasis (e.g., number of metastatic nodules).
Randomized Controlled Trial in Mice Evaluating Creatine Supplementation on Platelet Function and Metastasis in CKB Knockout vs Wild-Type Mice
Randomized, placebo-controlled trial in mice: CKB knockout and wild-type mice are randomized to creatine or placebo supplementation. Outcomes include platelet aggregation, activation markers, and number of metastatic lung nodules after tail vein injection of cancer cells. Duration: 4-6 weeks of supplementation followed by metastasis assessment.
Animal Model Study of Creatine-Induced Platelet Hyperactivity and Metastasis in Mice with Megakaryocyte-Specific CKB Expression
Controlled animal study using mice with megakaryocyte-specific CKB knockout or overexpression. Mice receive creatine or control. Platelet function tests (e.g., aggregation in response to ADP, collagen) and metastasis assays (e.g., intravenous injection of B16 melanoma cells) are performed. Outcome: platelet hyperactivity and number of metastatic foci in lungs.
In Vitro Study of Creatine-Mediated STAT5B Phosphorylation in Megakaryocyte Cell Lines
In vitro experiments using megakaryocyte cell lines (e.g., MEG-01) with or without CKB knockdown. Cells are treated with creatine, and phosphorylation of STAT5B is measured by Western blot. Additionally, expression of platelet functional genes (e.g., GPIb, GPIIb/IIIa) is assessed by qPCR. Controls include cells treated with CKB inhibitor or STAT5B inhibitor.